Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Could a Blood Test Revolutionize Alzheimer's Care?
Imaging & Diagnostics Could a Blood Test Revolutionize Alzheimer's Care?

For millions of families, the journey to an Alzheimer's diagnosis has long been a frustrating and arduous path paved with uncertainty, invasive procedures, and prolonged waiting periods for definitive answers. The traditional diagnostic toolkit, heavily reliant on expensive brain scans and

Could a Unified Platform Reshape Clinical Trials?
Imaging & Diagnostics Could a Unified Platform Reshape Clinical Trials?

The landscape of clinical research is currently navigating a complex and often fragmented technological terrain, where sponsors and contract research organizations (CROs) frequently juggle a patchwork of disparate systems to manage the lifecycle of a trial. This siloed approach creates significant

How Is AI Fueling Hinge Health's Dominance?
Digital Health How Is AI Fueling Hinge Health's Dominance?

In the rapidly evolving landscape of digital health, a company’s ability to scale operations without sacrificing quality of care has become the ultimate benchmark for success. Hinge Health, a prominent provider of digital musculoskeletal (MSK) care, is not just meeting this benchmark but redefining

AFib Symposium Spotlights New Ablation and Stroke Tech
Infrastructure & Management AFib Symposium Spotlights New Ablation and Stroke Tech

The recent 2026 Atrial Fibrillation Symposium in Boston served as a critical forum where the world’s leading cardiac device innovators showcased groundbreaking technologies, firmly establishing pulsed field ablation as the ascendant standard of care for treating this pervasive arrhythmia. Amidst a

Can AI Close the Women's Health Data Gap?
Patient Care Can AI Close the Women's Health Data Gap?

For decades, the field of women's hormonal health has been characterized by a pervasive trial-and-error approach, leaving millions grappling with complex conditions from contraception to menopause with imprecise guidance. The historical underrepresentation of women in medical research has created a

CMS Proposes Major Overhaul of ACA Insurance Marketplace
Regulatory & Compliance CMS Proposes Major Overhaul of ACA Insurance Marketplace

With the healthcare landscape in constant flux, the latest proposal from the Centers for Medicare & Medicaid Services aims to reshape the Affordable Care Act marketplaces. To help us understand these sweeping changes, we're speaking with James Maitland, a leading expert on U.S. health insurance

Ireland Launches Major Digital Health Record Overhaul
Digital Health Ireland Launches Major Digital Health Record Overhaul

For decades, a patient's medical history in Ireland has existed as a fragmented puzzle, scattered across disparate paper files and isolated digital systems, often leaving clinicians without a complete and real-time picture at critical moments of care. This long-standing challenge, where individuals

PSMA Scans Improve Recurrent Prostate Cancer Outcomes
Imaging & Diagnostics PSMA Scans Improve Recurrent Prostate Cancer Outcomes

A groundbreaking five-year retrospective study has provided compelling evidence that an advanced imaging technique is revolutionizing the management of recurrent prostate cancer. Researchers have demonstrated that prostate-specific membrane antigen (PSMA) PET/CT scans offer a highly sensitive tool

Oregon Bill Ends Cost for Cervical Cancer Follow-Ups
Imaging & Diagnostics Oregon Bill Ends Cost for Cervical Cancer Follow-Ups

An abnormal result from a routine cervical cancer screening can be a profoundly distressing experience, but for many in Oregon, that anxiety is immediately compounded by an unexpected and often insurmountable financial obstacle. This critical juncture, where timely follow-up is essential for a

Radiation Detector Market to Top $2.6 Billion by 2030
Imaging & Diagnostics Radiation Detector Market to Top $2.6 Billion by 2030

The silent and invisible nature of ionizing radiation presents a persistent challenge across numerous high-stakes industries, necessitating sophisticated technology to ensure safety and operational integrity. Responding to this critical need, the global radiation detection market is on a trajectory

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later